Brought to you by 
St. Jude Medical acquires Velocimed
Feb 2005
Executive Summary
St. Jude Medical has agreed to acquire Velocimed (develops, manufactures, and markets interventional cardiovascular devices) for $82.5mm in cash, plus an earnout of up to $180mm. Shareholders may also receive an earnout if the company reaches future revenue targets and gets FDA approval for its Premere patent foramen ovale (PFO) closure system.
Deal Industry
-
Medical Devices
- Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
- Includes Earnout
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
St. Jude Medical acquires Velocimed
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice